IPO Alert: Glenmark Life Sciences Ltd.
Glenmark Life Sciences Limited (“GLS”) is a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. The company is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”). GLS partners with 16 of the top 20 generic companies in the world and serves customers in multiple countries.
|Bid/Offer Opens On||Tuesday, 27-Jul-21|
|Bid/Offer Closes On||Thursday, 29-Jul-21|
|Price Band||Rs. 695- Rs. 720 per equity share|
|Lot Size||20 Shares|
|Finalization of Basis of Allotment||3-Aug-21|
|Initiation of Refunds||4-Aug-21|
|Credit of Shares to Demat Acct||5-Aug-21|
|IPO Shares Listing Date||6-Aug-21|
|UPI mandate expiry date||12-Aug-21|
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date as mentioned in the above table. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.